Class III · Lower riskRecall completed
Triamterene and Hydrochlorothiazide Capsules
Unlikely to cause harm — often a labeling or packaging issue.
Does this affect you?
Check your lot numberLots: 21000279A (exp 01/2023), 20256320A (12/2022)
Where it was soldNationwide USA
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Failed Impurity/Degradation Specifications
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
| Distributed by / for | Lannett Company, Inc., Philadelphia, PA 19136 |
Show the full FDA record
| Full product label | Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 or 1000 ] Capsules per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 100 Count bottle: 0527-1632-01; NDC 1,000 bottle: 0527-1632-10 |
| Recalling firm | Lannett Company Inc. |
| Distribution | Nationwide USA |
| Quantity | 20,040 bottles |
| Recall initiated | 2022-11-09 |
| Report date | 2023-01-25 |
| Recall completed | 2023-06-08 |
| Recall number | D-0161-2023 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Seymour IN United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.